Glycoprotein IIb/IIIa antagonists: Potential induction and detection of drug-dependent antiplatelet antibodies

American Heart Journal

Volumn 135, Issue 5 II, 1998, Pages

  Cines, D B ^a  

^a 513A Stelbychance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ANTIGEN BINDING; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031861876     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(98)70243-1     Document Type: Review

References (67)

1. U Pedersen-Bjergaard M Andersen PB. Hansen Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968-91 J Intern Med 239 1996 509 515
2. B-E Wiholm S. Emanuelsson Drug-related blood dyscrasias in a Swedish reporting system Eur J Haematol 57 suppl 1995 42 46
3. WR Bell RM. Royall Heparin-associated thrombocytopenia: a comparison of three heparin preparations N Engl J Med 303 1980 902 907
4. TE Warkentin MN Levine J Hirsh P Horsewood RS Roberts R Tech Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
5. KR McCrae DB. Cines Drug-induced thrombocytopenias 2nd ed J Loscalzo AI Schafer Thrombosis and hemorrhage. 1994 Blackwell Scientific Boston 545 573
6. X Jiang G Khursigara RL. Rubin Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils Science 256 1994 810 813
7. L Takorabet A Ropars C Raby J. Charreie Phenothiazine induces de novo MHC class II antigen expression on thyroid epithelial cells. A new mechanism for drug-induced autoimmunity J Immunol 154 1995 3593 3602
8. DO Singal B Reid D Green M D'Souza WG Bensen WW Buchanan Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis and gold induced thrombocytopenia or proteinuria Ann Rheumat Dis 49 1990 582 586
9. BP Schmitt B. Adelman Heparin-associated thrombocytopenia: a critical review and pooled analysis Am J Med Sci 305 1993 208 215
10. PL Cervi P Wright EB. Casey Audit of full blood count monitoring in patients on longterm gold therapy for rheumatoid arthritis Irish J Med Sci 16 1992 73 74
11. LM Lockie DM. Smith Forty-seven years experience with gold therapy in 1019 rheumatoid arthritis patients Semin Arth Rheum 17 1985 238 246
12. RB May TR. Sunder Hematologic manifestations of long-term valproate therapy Epilepsia 34 1993 1098 1101
13. GP Visentin PJ Newman RH. Aster Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa Blood 77 1991 2668 2676
14. BH Chong X Du MC Berndt S Horn CN. Chesterman Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies Blood 77 1991 2190 2199
15. DJ Christie RW Weber PC Mullen JM Cook RA. Aster Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets J Lab Clin Med 104 1984 730 740
16. DF Stroncek GM Vercellotti DE Hammerschmidt DJ Christie RA Shankar HS. Jacob Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis Blood 80 1992 241 248
17. JL Gottschall B Neahring JG McFarland G-G Wu LA Weitekamp RH. Aster Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of the literature Am J Hematol 47 1994 283 289
18. AEGKr von dem Borne JG Pegels RJ van der Stadt CM van der Plas-van Dalen FM. Helmerhorst Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease? Br J Haematol 63 1986 509 516
19. U Nieminen R. Kekomaki Quinidine-induced thrombocytopenic purpura: clinical presentation in relation to drug-dependent and drug-independent antibodies Br J Haematol 80 1992 77 82
20. W Lerner R Caruso D Faig S. Karpatkin Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura Blood 66 1985 306 311
21. J Amiral F Bridey M Dreyfus AM Vissac E Fressinaud M Wolf Platelet factor 4 complexed to heparin is the target for antibiotics generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95 96
22. A Greinacher B Potzsch J Amiral V Dummel A Eichner C Mueller-Eckhardt Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thrombos Haemost 71 1994 247 251
23. J Amiral A Marfaing-Koka M Wolf MC Alessi B Tardy C Boyer-Neumann Presence of autoantibodies to interleukin-8 or neutrophil-activating-peptide-2 in patients with heparin-associated thrombocytopenia Blood 88 1996 410 416
24. DB Cines A Tomaski S. Tannenbaum Immune endothelial cell injury in heparin-associated thrombocytopenia N Engl J Med 316 1987 581 589
25. A Greinacher U Liebenhoff V Kiefel P Presek C Mueller-Eckhardt Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation—a possible new indication for high dose IV IgG Thrombos Haemost 71 1994 641 645
26. P Williamson EM Bevers EF Smeets P Comfurius RA Schlegel RFA. Zwaal Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets Biochem 34 1995 10448 10455
27. C Zamarron MH Ginsberg EF. Plow Monoclonal antibodies specific for a conformationally altered state of fibrinogen Thrombos Haemost 64 1990 41 46
28. J Dachary-Prigent J-M Freyssinet J-M Pasquet J-C Carron AT. Nurden Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups Blood 81 1993 2554 2565
29. SJ Shattil JA Hoxie MC Cunningham LF. Brass Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation J Biol Chem 260 1985 11107 11114
30. PJ Sims MH Ginsburg EF Plow SJ. Shattil Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb/IIIa complex J Biol Chem 266 1991 7345 7352
31. C Zamarron MH Ginsburg EF. Plow A receptor-induced binding site in fibrinogen elicited by its interaction with platelet membrane glycoprotein IIb/IIIa J Biol Chem 266 1991 16193 16199
32. TH Mondoro CD Wall MM White LK. Jennings Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor Blood 88 1996 3824 3830
33. AL Frelinger I Cohen EF Plow MA Smith J Roberts SC Lam Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor confomers J Biol Chem 265 1990 6346 6352
34. AL Freilinger SC Lam EF Plow MA Smith JC Loftus MH. Ginsburg Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion J Biol Chem 263 1988 12397 12402
35. AD. Michaelson Flow cytometry: a clinical test of platelet function Blood 87 1996 4925 4936
36. K Fujisawa TE O'Toole P Tani JC Loftus EF Plow MH Ginsberg Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura Blood 77 1991 2207 2213
37. BS. Coller Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics J Clin Invest 99 1997 1467 1471
38. DJ Simon H Xu S Ortlepp C Rogers NK. Rao 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1 Arterioscler Thromb Vasc Biol 17 1997 528 535
39. HJ Weiss MH Rosove BA Lages KL. Kaplan Acquired storage pool deficiency with increased platelet-associated IgG: report of five cases Am J Med 69 1980 711 717
40. R Clancy E Jenkins B. Firkin Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura N Engl J Med 286 1972 622 626
41. R McMillan RD Bowditch P Tani H Anderson S. Goodnight A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/IIIa autoantibody Br J Haematol 95 1996 747 749
42. E Griffiths WH. Dzik Assays for heparin-induced thrombocytopenia Transfus Med 7 1997 1 11
43. DH Lee TE Warkentin GA Denomme CPM Hayward JG. Kelton A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry Br J Haematol 95 1996 724 731
44. EV Eisner K. Kaspar Immune thrombocytopenia due to a metabolite of paraminosalicylic acid Am J Med 53 1972 790 796
45. EV Eisner NT. Shahidi Immune thrombocytopenia due to a drug metabolite N Engl J Med 287 1972 376 381
46. A Salama C. Mueller-Eckhardt The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia N Engl J Med 313 1985 469 474
47. JK Burgess R Lindeman CN Chesterman BH. Chong Single amino acid mutation of FcgR receptor is associated with the development of heparin-associated thrombocytopenia Br J Haematol 91 1995 761 766
48. JR Kappa CA Fisher HD Berkowitz ED Cottrell VP Addonizio Jr. Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management J Vasc Surg 5 1987 101 109
49. SL Pfueller RA Bilston D Logan JM Gibson BG. Firkin Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine-and quindine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, IX Blood 72 1988 1155 1162
50. HH Salem van der Weyden Heparin induced thrombocytopenia. Variable platelet-rich plasma reactivity to heparin dependent platelet aggregating factor Pathology 15 1983 297 299
51. JG Kelton D Meltzer J Moore Drug-induced thrombocytopenia is associated with increasing binding of IgG to platelets both in vivo and in vitro Blood 58 1981 525 529
52. JN George S Saucerman SP Levine LK. Knieriem Immunoglobulin is a platelet alpha granule-secreted protein J Clin Invest 76 1985 2020 2025
53. JN George EB Pickett S Saucerman RP McEver TJ Kunicki N Kieffer Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery J Clin Invest 78 1986 340 348
54. J Amiral F Bridey M Wolf C Boyer-Neumann E Fressinaud AM Vissac Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases Thrombos Haemost 73 1995 21 28
55. 14 C-serotonin release assay in the diagnosis of heparin associated thrombocytopenia/thrombosis Am J Clin Pathol 104 1995 648 654
56. GP Visentin M Malik KA Cyganiak RH. Aster Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet 4 complexes J Lab Clin Med 128 1996 376 383
57. TL Bauer G Arepally BA Konkle B Mestichelli SS Shapiro DB Cines Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass Circulation 95 1997 1242 1246
58. J-S Suh MI Malik RH Aster GP. Visentin Characterization of the humoral immune response in heparin-induced thrombocytopenia Am J Hematol 54 1997 196 201
59. B Bednar RA Bednar JJ Cook DM Bollag CT Chang SL Gaul PA McQueney Drug-dependent antibodies against GPIIb/IIIa induce thrombocytopenia [abstract] Circulation 94 suppl I 1996 I99
60. N. Bizzao EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10 year follow-up Am J Hematol 50 1995 103 109
61. E Muniz-Diaz P Madoz N Pujol-Moix C Pastoret M Arilla M Ibanez Characterization of antibodies directed against platelet cryptantigens detected during the immunologic study of 356 consecutive patients with presumed autoimmune thrombocytopenia (AITP) Transfus Med 5 1995 185 191
62. SD Berkowitz RA Harrington MM Rund JE. Tcheng Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy Circulation 95 1997 809 813
63. TK Liem R Teel S Shukla D. Silver The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies J Vasc Surg 25 1997 124 130
64. C Simpfendorfer K Kottke-Marchant M Lowrie RJ Anders DM Burns DP Miller First chronic platelet glycoproteinIIb/IIIa integrin blockage. A randomized, placebo-controlled pilot study of Xemilofiban in unstable angina with percutaneous coronary interventions Circulation 96 1997 76 81
65. F Catella-Lawson S Kapoor W Skammer DJ Fitzgerald B Rocca JF Tamby Chronic inhibition of the platelet glycoprotein IIb/IIIa by a new oral agent:dose escalation study in patients with coronary artery disease (CAD) [abstract] Thrombos Haemost 77 Suppl 1997 393
66. CP Cannon CH McCabe S Borzak TD Henry MC Tischler HS Mueller Randomized trial of an oral platelet IIb/IIIa antagonist, ibrafiban, in patients after an acute coronary syndrome. Results of the TIMI 12 Trial Circulation 97 1998 340 349
67. TH Muller H Wesienberger R Brickl H Narjes F. Himmelsbach Profound and sustained inhibition of platelet aggregation by radafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, efradafiban, in men Circulation 96 1997 1130 1138